SAP, Dell, and Intel Speed Time-to-Value for Powerful Health Analytics

A health-related revolution is transforming industries such as healthcare, life sciences, higher education, consumer products, and the public sector. Empowered by automated diagnosis and treatment options, along with better access to information, patients are taking charge of their healthcare experience like never before. Today's activist health consumers expect medical decisions and products to be tailored to their specific needs and goals, so they can live full and healthy lives.

Advances in big data analytics provide powerful new ways to meet these demands. Using the SAP Connected Health platform, built on SAP HANA®, organizations can combine and analyze traditional data sources and vital patient data—clinical, research, personal medical, social information, and more. Armed with fresh analytic insights, organizations can accelerate their development of personalized, patient-centered treatments and innovations, including drugs, therapies, devices, and diagnostic tests. These insights can also help deepen understanding of the patient and expand patient involvement, to improve prevention, diagnosis, treatment, and patient care.

Download: SAP, Dell, and Intel Speed Time-to-Value for Powerful Health Analytics (.pdf, 384 KB).

Download from eHealthNews.eu: SAP, Dell, and Intel Speed Time-to-Value for Powerful Health Analytics (.pdf, 384 KB).

Most Popular Now

Free Online Tool Helps Determine Whether…

University of California, Irvine health sciences researchers have created a machine-learning model to predict the probability that a COVID-19 patient will need a ventilator or ICU care. The tool is...

Study Details First Artificial Intellige…

Hospital-based laboratories and doctors at the front line of the COVID-19 pandemic might soon add artificial intelligence to their testing toolkit. A recent study conducted with collaborators from the University...

Accelerating Data Solutions to Save LIVE…

The consortium of COVID-X announces the launch of the ​1st Open Call ​framed in a ​2-year initiative that will invest ​4 million € to fast-track to market 30+ European data...

Significant Disparities in Telemedicine …

After "COVID-19," the term that most people will remember best from 2020 is likely to be "social distancing." While it most commonly applied to social gatherings with family and friends...

Model Used to Evaluate Lockdowns was Fla…

In a recent study, researchers from Imperial College London developed a model to assess the effect of different measures used to curb the spread of the coronavirus. However, the model...

New Virtual Screening Strategy Identifie…

A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat COVID-19. Haiping Zhang...

Using Artificial Intelligence to Find Ne…

Scientists have developed a machine-learning method that crunches massive amounts of data to help determine which existing medications could improve outcomes in diseases for which they are not prescribed. The intent...

One in Four Doctors Attacked, Harassed o…

While many physicians benefit from social media by networking with potential collaborators or interfacing with patients, a new study from Northwestern University and the University of Chicago found many physicians...

CliniSys Launches Laboratory Information…

CliniSys has launched a new laboratory information management system for genomic laboratories in the UK. The company has brought GLIMS Genomics to the UK from Europe, where it is being...

The Institute of Healthcare Management C…

The Institute of Healthcare Management has called for honest and open communication about NHS capacity after a snapshot survey revealed the scale of sickness absence across the service. The UK's leading...